A Study To Estimate The Effect Of Omeprazole On The Pharmacokinetics Of Nelfinavir In Healthy Subjects

Pfizer

Status and phase: Completed; Phase 4

Conditions: Healthy Volunteers

Treatments: Drug: Nelfinavir and Omeprazole

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT00251030

A4301024

Details and patient eligibility

About

To estimate the effects of omeprazole on the pharmacokinetics of nelfinavir in healthy subjects

Enrollment: 20 patients

Sex: All

Ages: 18 to 55 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Healthy male or female subjects between the ages of 18 and 55 years.

Exclusion criteria

• Subjects with hematological, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, psychiatric, neurologic, or allergic disease.

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Crossover Assignment

Masking: None (Open label)